Cited by 1,837Advanced Drug Delivery SystemsNanocomposite Films for Food PackagingTissue Engineering and Regenerative Medicine

Biodegradation, biodistribution and toxicity of chitosan

Kean, T., Thanou, M.·2010·Advanced Drug Delivery Reviews

Abstract

Chitosan is a natural polysaccharide that has attracted significant scientific interest during the last two decades. It is a potentially biologically compatible material that is chemically versatile (-NH2 groups and various M(w)). These two basic properties have been used by drug delivery and tissue engineering scientists to create a plethora of formulations and scaffolds that show promise in healthcare. Despite the high number of published studies, chitosan is not approved by the FDA for any product in drug delivery, and as a consequence very few biotech companies are using this material. This review will aim to provide information on these biological properties that affect chitosan's safe use in drug delivery. The term "Chitosan" represents a large group of structurally different chemical entities that may show different biodistribution, biodegradation and toxicological profiles. Here we aim to review research in this area and critically discuss chitosan's potential to be used as a generally regarded as safe (GRAS) material.

Integrity signals

Registry

Crossref · 10.1016/j.addr.2009.09.004

Cites

93 of 93 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Practical limitations of chitosan include variability in molecular weight and degree of deacetylation due to natural sourcing from shellfish, as well as regulatory hurdles.

    “However, practical limitations include variability in molecular weight and degree of deacetylation due to its natural sourcing from shellfish, as well as regulatory hurdles.”
  • Although chitosan is classified as Generally Recognized as Safe by the U.S. FDA for certain food applications, its medical-grade use requires rigorous purification to meet endotoxin, sterility, and biocompatibility standards, which can complicate clinical translation.

    “Although chitosan is classified as Generally Recognized as Safe (GRAS) by the U.S. FDA for certain food applications, its medical-grade use—especially in injectable or implantable products—requires rigorous purification to meet endotoxin, sterility, and biocompatibility standards, which can complicate its clinical translation [149].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kean, T., & Thanou, M.
Affiliations
  • Case Western Reserve University (US)
  • King's College London (GB)
Corresponding author
Thanou, M.
Venue
Advanced Drug Delivery Reviews
Publisher
Elsevier BV
Published
2010-01
Volume
62
Issue
1
Pages
3-11
ISSN
0169-409X (ISSN-L)
OpenAlex
W2154899729
Cited by
1,837
References
93
Citations by year
2026: 90 · 2025: 112 · 2024: 124 · 2023: 127 · 2022: 143 · 2021: 158 · 2020: 148 · 2019: 148 · 2018: 115 · 2017: 123 · 2016: 113 · 2015: 110 · 2014: 80 · 2013: 80 · 2012: 80
FWCI
5.65
Type
journal article
Language
en
Open access
closed
Locations
  • Advanced Drug Delivery Reviews (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Physical Sciences › Materials Science › Biomaterials › Nanocomposite Films for Food Packaging
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
Keywords
chitosan, biodegradation, tissue distribution, toxicity, drug delivery, tissue engineering scaffolds, GRAS, FDA approval
MeSH terms
Animals, Biotransformation, Humans, Tissue Distribution, Drug Delivery Systems, Chitosan

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review